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Background: Exposure to inorganic arsenic (iAs) through drinking water causes cancer.
Alterations in mitochondrial DNA copy number (mtDNAcn) and telomere length in blood
have been associated with cancer risk. We elucidated if arsenic exposure altersmtDNAcn
and telomere length in individuals with different arsenic metabolizing capacity.
Methods: We studied two groups in the Salta province, Argentina, one in the Puna
area of the Andes (N = 264, 89% females) and one in Chaco (N = 169, 75% females).
We assessed arsenic exposure as the sum of arsenic metabolites [iAs, methylarsonic
acid (MMA), dimethylarsinic acid (DMA)] in urine (U-As) using high-performance liquid
chromatography coupled with hydride generation and inductively coupled plasma mass
spectrometry. Efficiency of arsenic metabolism was expressed as percentage of urinary
metabolites. MtDNAcn and telomere length were determined in blood by real-time PCR.
Results: Median U-As was 196 (5–95 percentile: 21–537) µg/L in Andes and 80 (5–95
percentile: 15–1637)µg/L in Chaco. The latter study group had less-efficient metabolism,
with higher %iAs and %MMA in urine compared with the Andean group. U-As was
significantly associated with increased mtDNAcn (log2 transformed to improve linearity)
in Chaco (β = 0.027 per 100µg/L, p = 0.0085; adjusted for age and sex), but not in
Andes (β = 0.025, p = 0.24). U-As was also associated with longer telomere length in
Chaco (β= 0.016, p= 0.0066) and Andes (β= 0.0075, p = 0.029). In both populations,
individuals with above median %iAs showed significantly higher mtDNAcn and telomere
length compared with individuals with below median %iAs.
Conclusions: Arsenic was associated with increased mtDNAcn and telomere length,
particularly in individuals with less-efficient arsenic metabolism, a group who may have
increased risk for arsenic-related cancer.
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Ameer et al. Arsenic, mtDNAcn and Telomere Length
INTRODUCTION
Elevated arsenic concentrations in drinking water occur in many
countries, e.g., in Argentina, Bangladesh, India, and some parts
of the U.S.A. Arsenic exposure is a known risk factor for
different types of malignancies, mainly of epithelial origin, such
as cancer of the lung, bladder, kidney, skin, liver, and prostate
(International Agency for Reseasrch on Cancer, 2012). However,
the mechanisms behind the carcinogenic effect of arsenic have
not been completely clarified.
The susceptibility to arsenic differs between individuals and
a key factor for individual susceptibility is the capacity to
metabolize arsenic and excrete it efficiently. Inorganic arsenic
(iAs) is metabolized to methylarsonic acid (MMA), and further,
to dimethylarsinic acid (DMA). In humans, like most mammals,
efficient methylation from iAs to DMA is associated with
decreased reactivity and increased rate of urinary arsenic
excretion (Vahter, 2002; Gardner et al., 2011). The degree of
methylation to DMA varies within and between individuals
and populations suggesting a genetic component for the arsenic
metabolism (Vahter, 2002). Incomplete arsenic metabolism
seems to be a marker of increased susceptibility to arsenic-related
diseases: individuals with high fraction of inorganic arsenic
and/or MMA in urine have higher risk for skin lesions and
skin cancer (Lindberg et al., 2008; Pilsner et al., 2009; Antonelli
et al., 2014; Engström et al., 2015) and cardiovascular disease
(Chen et al., 2013; Wu et al., 2015) compared to individuals
with low fraction of inorganic arsenic and/or MMA in urine.
Genetic variation in arsenite methyltransferase (AS3MT), which
encodes the major arsenic-methylating enzyme, significantly
contributes to arsenic metabolism efficiency (Engström et al.,
2011; Schlebusch et al., 2013, 2015) and is likely an underlying
factor partly determining variation in susceptibility to arsenic
between individuals and populations (Hossain et al., 2012; Pierce
et al., 2013; Engström et al., 2015).
Telomeres, the tandem repeats (TTAGGG) at the ends of
the chromosomes, protect the chromosomes from recombination
and degradation (Blasco, 2005), which could lead to genome
instability. In cross-sectional and prospective studies, alterations
in telomere length in peripheral blood have been associated with
increased risk for several types of cancer (Ma et al., 2011), such as
cancers in the head and neck, bladder, breast, skin and lung (Wu
et al., 2003;McGrath et al., 2007; Shen et al., 2007, 2011; Han et al.,
2009; Seow et al., 2014). Previously, we (Li et al., 2012) and others
(Zhang et al., 2013) reported that arsenic in urine was associated
with longer telomeres in peripheral blood suggesting that arsenic
modifies the individual telomere length.
Another cancer-related genetic component is the
mitochondrial DNA (mtDNA). The mitochondrion is the
key organelle for energy metabolism, but it also has important
functions in the regulation of apoptosis (Lee and Wei, 2000)
and cell proliferation (Martinez-Outschoorn et al., 2011). Recent
findings have suggested that mitochondrial metabolic disease
can lead to cancer (Seyfried, 2015). Mitochondria possess their
own extra-nuclear circular DNA that exists in different copy
numbers (mtDNAcn) in each mitochondrion. Mitochondria
generate high levels of reactive oxygen species (ROS) during
energy production. Lack of introns and protective histones and
its proximity to the electron transport chain make the mtDNA
highly susceptible to oxidative damage (Van Houten et al., 2006).
Alterations in mtDNAcn may be associated with cancer risk as
indicated by case-control and prospective cohort studies which
have shown that mtDNAcn is associated with increased risk
of cancer in the breast, head and neck, prostate, kidney and
colon/rectum in women (Thyagarajan et al., 2013; Cheau-Feng
Lin et al., 2014; Huang et al., 2014; Zhou et al., 2014; Lemnrau
et al., 2015; Melkonian et al., 2015).
We have previously reported that the indigenous people
living in the Andean part of the Salta province in the northern
Argentina, the so called Puna area, have a unique capacity of
metabolizing inorganic arsenic, mainly due to presence of genetic
polymorphisms in AS3MT, which is one of the main genes
regulating arsenic methylation (Vahter et al., 1995; Engström
et al., 2011; Schlebusch et al., 2013, 2015). Other areas in Salta
province, such as Chaco, situated in the eastern part of the
Salta province, also have arsenic-contaminated drinking water
(Concha et al., 1998). People living in Chaco are mainly of mixed
ethnicity (descendants of Spanish/European). The local health
authority in Salta invited our group to conduct a study there
with the aim to compare the populations from the Andes and the
Chaco regions for arsenic metabolism and toxicity. Thus, the aim
of the present study was to evaluate the effect of arsenic, including
modifying effects of the arsenic metabolizing capacity, on the
cancer-related markers telomere length and mtDNAcn in two
arsenic-exposed study groups with different genetic background
in northern Argentina.
MATERIALS AND METHODS
Study Areas and Study Participants
Andes
Two hundred and sixty four individuals, including men (n =
28) and women (n = 236), were recruited in 2008 (n =
218) and 2011 (n = 46) in the Puna area of the Andes
Mountains (about 3800m above sea level) in the province of
Salta, northern Argentina. The recruitments in 2008 and 2011
were performed in a similar way and individuals who participated
in 2008 were not recruited in 2011. Most of the individuals
were living in the village of San Antonio de los Cobres (n =
192), which has elevated arsenic concentrations in the drinking
water (∼200µg/L), and 72 individuals were living in small
surrounding villages with lower water arsenic concentrations
(3.5–70µg/L) (Concha et al., 2010). The source of drinking water
in San Antonio de los Cobres is a natural spring, Agua de
Castilla, located about 1 km outside the village, and the water is
chlorinated before being distributed through pipes to the village
(Concha et al., 2010). The total population of San Antonio de los
Cobres and surrounding villages is about 8100 inhabitants, and
are mainly of indigenous origin (Kolla ethnicity).
Details of the recruitments have been described elsewhere
(Engström et al., 2011). Briefly, individuals were interviewed
about their age, ancestry, time of residence, drinking water
sources, dietary habits, medical history, smoking, alcohol
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consumption, coca chewing, as well as parity (for women). Also,
weight and height were measured and used for calculation of
body mass index (BMI). We have previously reported a positive
association of arsenic exposure with telomere length in the
women recruited from this study area in 2008 (Li et al., 2012).
Chaco
One hundred and sixty-nine individuals were recruited in
the Chaco and Anta areas east of the city of Salta (up to
300m above sea level); here referred to as participants from
Chaco. Individuals in Chaco were informed about the study
by radio announcements, by primary health care workers, and
by contacting individuals in the lines at the post-office. In
the Rivadavia hospital the patients’ attendants were asked to
participate and those who wanted to volunteer were included in
the study. Individuals were living in different areas [El Rincón
(n = 25), Los Rosales (n = 22) and other villages in rural
Anta county (n = 36); Rivadavia (n = 26), La Unión
(n = 12) and Nueva Población (n = 6) in Rivadavia county;
and El Galpón (n = 42) in Metán county]. The recruitment
was performed in 1999 (Anta) and 2013 (all other areas). The
arsenic concentrations in drinking water (mainly well water)
varied between 110 and 837µg/L in Anta (several water sources),
4.7µg/L in El Galpón (samples collected from several small
villages), about 230µg/L in Rivadavia, 72µg/L in Los Rosales,
983µg/L in Nueva Población and 23µg/L in La Unión. The total
population in Anta is ∼8000 inhabitants, in El Galpón ∼8400,
and in Rivadavia, and La Unión 6400. The people are mostly
“creoles,” i.e., of Spanish/European descents. Sampling was done
following the standard procedure developed by Unit of Metals
and Health, Institute of Environmental Medicine at Karolinska
Institutet, and the study participants in Chaco were asked similar
questions as in the Andes.
Men and women, 16 years and older, were included in
the study. The Health Ministry of Salta (Salta, Argentina) and
the Regional Ethical Committee at the Karolinska Institutet
(Stockholm, Sweden) approved the study. Oral and written
informed consent was obtained from all study participants.
Urine and Blood Sampling
Spot urine and blood samples were collected from all study
participants and the sample collection was performed throughout
the day. Mid-stream urine samples were collected in plastic
urine collection cups and then transferred to 24mL polyethylene
tubes and immediately frozen. Peripheral blood samples were
collected in K2EDTA tubes (Vacuette; Greiner Bio-One, Greiner,
Germany) for DNA isolation.
Analysis of Arsenic Exposure
We measured total arsenic concentrations in water samples
collected from the Andes and Chaco regions by inductively
coupled plasma mass spectrometry (ICPMS: Agilent 7500ce;
Agilent Technologies, Tokyo, Japan) as previously described
(Concha et al., 2010). Water from rural Anta was analyzed
by atomic absorption spectrophotometry (AAS) (Concha et al.,
2006). We did not perform speciation of arsenic in the water.
Most of the absorbed pentavalent arsenic is rapidly reduced in
blood (Vahter, 2002), before the trivalent form (but not the
pentavalent) is taken up by the hepatocytes where it is methylated
(Lerman et al., 1983). Exposure to arsenic was determined based
on the sum of concentrations of iAs and its metabolites (MMA+
DMA) in urine (U-As). We assessed the efficiency of arsenic
metabolism by the fractions (percentages) of iAs, MMA, and
DMA in urine (Vahter, 2002). Arsenic metabolites in urine were
measured by high-performance liquid chromatography (HPLC:
Agilent 1100 series system, Agilent Technologies, Waldbronn,
Germany) coupled with hydride generation (HG) and ICPMS
(HPLC-HG-ICPMS) as described previously (Gardner et al.,
2011). Urine samples from rural Anta was analyzed for arsenic
metabolites by HPLC-AAS, as previously described (Concha
et al., 2006). To compensate for variation in dilution of urine,
the arsenic concentrations were adjusted to the mean specific
gravity, measured by a hand refractometer (Atago, Japan) or a
digital refractometer (EUROMEX RD 712 clinical refractometer;
EUROMEX, Arnhem, the Netherlands). We evaluated the data
using overall specific gravity value of 1.020 for adjustment for all
samples.
Analysis of Mitochondrial DNA Copy
Number
Human mtDNA is a small, double-stranded DNA encoding 22
tRNAs, 2 rRNAs, and 13 genes that code for protein subunits
of the electron transport chain complexes. The primers were
selected from the mtDNA tRNA region, because other mtDNA
regions are highly polymorphic and may contain common
deletions. The mitochondrial tRNALeu (UUR) gene region is
rarely deleted and contains only a few rare single nucleotide
polymorphisms (mtSNP) (Venegas and Halberg, 2012). The
relative mtDNAcn was measured based on the method by
Hou et al. (2010) by using real-time PCR (7900HT, Applied
Biosystems, Foster City, CA, U.S.A.).Mastermixes were prepared
with KAPA SYBR FAST qPCR Kit Master Mix (2X) ABI Prism
(Kapa Biosystems, Woburn, MA, U.S.A.), and primers (0.20µM
for each primer) for mtDNAcn were: forward 5′-CAC CCA AGA
ACA GGG TTT GT-3′ and reverse 5′-TGG CCA TGG GTA
TGT TGT TA-3′; and primers for the hemoglobin beta (HBB)
gene were: forward 5′-TGT GCT GGC CCA TCA CTT TG-3′
and reverse 5′-ACC AGC CAC CAC TTT CTG ATA GG-3′.
The mtDNA amplicon is 107 bp long and the mtDNA primers
are specific to mtDNA as evaluated by BLAST (https://blast.ncbi.
nlm.nih.gov/Blast.cgi)(Gen bank accession number: Accession
no: NC 012920.1). Each reaction (end volume 10µl) consisted
of 2.5µl of DNA (4 ng/µl) and 7.5µl master mix. The thermal
cycle profile was 95◦C for 3min, followed by 95◦C for 3 s and
60◦C for 20 s for 25 cycles (mtDNAcn) or 35 cycles (HBB).
A standard curve, one control sample, and a sample with
no template were also included in each run. All samples and
standard curve points were run in triplicate. For the standard
curve, one reference DNA sample was diluted serially twofold to
produce five concentrations of 1–16 ng/µl. R2 for each standard
curve was >0.99. Standard deviations of <0.1 were accepted
for the Ct values of each triplicate. SDS 2.4.1 software (Life
Technologies) calculated the relative quantity of mtDNAcn and
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HBB for each sample, based on the standard curve. The relative
mtDNAcn was the quotient of the quantity of mtDNAcn and
HBB, and thus, it is an arbitrary value. The coefficient of variation
(CV) of the control sample included in every run was 12%.
Analysis of Telomere Length
DNA was isolated from peripheral blood with the Qiagen
DNA blood Midi kit (Qiagen, Hilden, Germany). The relative
telomere length was measured using real-time PCR (7900HT),
as described previously (Li et al., 2012). Briefly, the master mix
for telomere length determination was prepared with telomere-
specific primers (0.45µM of each primer), 1 × PCR Buffer (all
PCR reagents from Life Technologies) 1.75mM MgCl2, 0.8mM
dNTPs, 0.3mM SYBR Green, 1 × Rox, and 0.5 U Platinium
Taq. Master mix for HBB runs were prepared with HBB primers
(0.40µM for each primer) and KAPA SYBR FAST qPCR Kit
Master Mix (2X) ABI Prism (Kapa Biosystems). Five microliters
of sample DNA (4 ng/µl) was added to each reaction (final
volume 20µl). A standard curve, a reference DNA, and a negative
control were also included in each run, all samples, standards,
and controls were run in triplicate. For the standard curve,
one calibrator DNA sample was diluted serially by twofold, to
produce concentrations of 1–16 ng/µl. R2 for each standard
curve was >0.99. Standard deviations (for Ct values of each
triplicate) were accepted at <0.1. The relative length of the
telomeres was obtained through calculating the ratio (T/S) of
the telomere repeat product to a single-copy gene product (S,
here HBB) for each individual, by the formula T/S = 2−1Ct,
where 1Ct = Cttelomere − CtHBB. This ratio was then compared
with the ratio of the reference DNA. The telomere length ratio
is an arbitrary value. The CV of the reference DNA included
in every run was 9.8%. The telomere length for subjects in the
Andes andChaco weremeasured at two different time-points and
with different reference DNAs. To make the data comparable, we
measured the ratio between the two different reference DNAs and
adjusted the values of Andes by this ratio, so that all data were
based on the same reference DNA.
Statistical Analyses
Statistical analyses were performed using SPSS software, version
22 (IBM, Chicago, IL, USA). Statistical significance refers to
p < 0.05. Data from the study groups in the Andes and Chaco
were analyzed separately.
Mann-Whitney U test was used to evaluate the differences
in characteristics of the study participants between the study
groups. In order to investigate how the characteristics differed
with U-As, we stratified U-As into tertiles to evaluate potential
non-linear differences in characteristics by Jonckheere-Terpstra
trend test.
We evaluated the associations between U-As, mtDNAcn,
telomere length and potentially confounders (age, gender, BMI,
and chewing of coca leaves) using Spearman’s rank correlation
coefficient. The linearity between U-As and mtDNAcn as well
as U-As and telomere length were inspected using scatter plots.
In order to improve linearity between U-As and mtDNAcn, we
log2-transformed mtDNAcn for both Andes and Chaco. Linear
regression analyses were performed to evaluate the associations
between U-As and log2-mtDNAcn, and U-As and telomere
length. The crude model (model 1) included only U-As and the
adjusted model (model 2) included age and gender as covariates
(confounders). Age and gender were selected as covariates based
on the knowledge from published literature. Other covariates
such as BMI and coca chewing were considered for adjustments
in sensitivity analyses (see below).
The influence of efficiency of arsenic metabolism on the
associations between U-As and log2-mtDNAcn or U-As and
telomere length were analyzed by including an interaction
term between U-As and the fraction of each metabolite
separately (defined as above and below median of %iAs, %MMA,
or %DMA). We also performed linear regression analyses with
individuals stratified by median values of the U-As metabolites.
Several sensitivity analyses were performed. The differences
in telomere length or mtDNAcn could reflect alterations in cell
composition. We therefore analyzed the associations between
U-As and log2-mtDNAcn as well as U-As and telomere length
in a subgroup (n = 79 Andean women) where we adjusted
for estimated fractions of cell types (CD4 and CD8 T-cells, B-
cells, natural killer cells, monocytes, and granulocytes) in blood.
The cell composition was derived from epigenetic signatures
of cells retrieved from whole-genome DNA methylation data
using Infinium HumanMethylation 450 K BeadChip [lllumina,
CA, U.S.A., Engström et al., 2013] and was estimated by the
method by Houseman et al. (2012), which estimates the relative
proportion of pure cell types within a sample, where the DNA
methylation signature is a surrogate for the distribution of white
blood cells. We also did sensitivity analysis for chewing of coca
leaves in the Andes only, since none of the participants chewed
coca-leaves in Chaco. We had information about smoking and
BMI for a few individuals in Chaco and mainly from individuals
with low exposure to arsenic; therefore sensitivity analyses
with adjustments for smoking or BMI were not considered
meaningful. Further, few individuals (n = 6) in Chaco reported
hyperkeratosis, we also performed sensitivity analyses excluding
those individuals to see the effect of arsenic on mtDNAcn and
telomere length in rest of the Chaco population.
RESULTS
Characteristics of the Study Groups
The general characteristics of the two study groups are presented
in Table 1 (characteristics stratified by tertiles of U-As are
presented in Supplementary Material Table S2) and the drinking
water concentrations in the different villages are presented in
Supplementary Material Table S1. The arsenic concentrations
in water showed a large range both in Andes and Chaco and
the corresponding U-As concentrations indicated that the major
exposure source to arsenic was the drinking water (Andes: rS =
0.72, p < 0.001; Chaco: rS = 0.87, p < 0.001). The study
groups differed in height and weight, where individuals in Andes
were shorter and weighed less than in Chaco. Most participants
were women; 11% in Andes and 25% in Chaco were men.
We observed a trend of increase in BMI by increasing U-As
concentrations in Chaco (Supplementary Material Table S2). The
overall median U-As was 196µg/L and 80µg/L for the Andes
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TABLE 1 | Characteristics of the Andes and Chaco study groups.
Andes Chaco
Variable n Median 5/95 percentile n Median 5/95 percentile p-value a
Age (years) 264 35 20 to 65 169 39 18 to 69 0.078
Sex 264 89% female 169 75% female <0.001
Height (cm) 264 153 144 to 167 127 158 148 to 174 <0.001
Weight (kg) 264 59 45 to 84 127 63 43 to 92 0.023
BMI (kg/m2) 264 25 19 to 35 127 25 18 to 36 0.80
Parity 243 3 0 to 11 No data
Arsenic in urine (µg/L) 264 196 21 to 537 169 80 15 to 1637 <0.001
iAs in urine (%) 264 11 4.3 to 23 169 17 5.6 to 34 <0.001
MMA in urine (%) 264 7.9 4.0 to 14 169 10 3.0 to 22 <0.001
DMA in urine (%) 264 81 66 to 91 169 71 49 to 86 <0.001
mtDNAcnb 244 0.57 0.33 to 1.0 159 0.84 0.44 to 1.5 <0.001
Telomere lengthb 208 0.43 0.30 to 0.58 159 1.10 0.73 to 1.7 <0.001
ap-value is derived from the Mann-Whitney U-test.
bThe relative mtDNAcn/telomere length was the quotient of the quantity of mtDNAcn/telomere and HBB, and thus, it is an arbitrary value.
and Chaco study groups, respectively. The metabolite pattern
differed significantly between the study groups: the median
% iAs and %MMA were higher and the median %DMA was
lower in Chaco compared with the Andes (Table 1). The %iAs
increased and %DMA decreased significantly with increasing U-
As tertiles in the Andes, and %MMA increased and %DMA
decreased significantly with increasing U-As tertiles in Chaco
(Supplementary Material Table S2).
The median values of relative mtDNAcn and the relative
telomere length differed significantly between the study groups,
where participants in Chaco had higher mtDNAcn and telomere
length than participants in Andes (p < 0.001, Table 1).
The median values of mtDNAcn and telomere length differed
significantly between the U-As tertiles in Chaco (Supplementary
Material Table S2). MtDNAcn and telomere length were
positively correlated (Andes, rS = 0.14, p = 0.054; Chaco,
rS = 0.29, p < 0.001). Telomere length was negatively correlated
with age in both study groups (Andes rS = −0.31, p < 0.001,
Chaco rS = −0.36, p < 0.001), while mtDNAcn was not
correlated with age in any of the groups. The median mtDNAcn
differed between the sexes; it was lower for men in Andes but
lower for women in Chaco (Andes: women = 0.58, men = 0.54,
p = 0.15; Chaco: women = 0.77, men = 0.98, p = 0.001).
The median telomere length was higher for men in Chaco, but it
did not differ between the sexes in the Andes (Andes: women =
0.43, men = 0.43, p = 0.29; Chaco: women = 1.06, men = 1.21,
p = 0.031).
The study group fromChaco included six study participants in
a family clinically diagnosed with arsenic related hyperkeratosis.
These six participants had very high U-As concentrations
(median 1943µg/L; range 623–2258µg/L) and also high %MMA
in urine (average 21%; range 18–24%) compared with the
other study participants in Chaco (Supplementary Material Table
S3). Their telomere length did not differ from the rest of the
participants in Chaco, but their mtDNAcn was higher (median
relative values 1.1 vs. 0.83).
Arsenic Exposure, Mitochondrial DNA
Copy Number, and Telomere Length
We observed linear relationships between U-As and log2-
mtDNAcn, as well as U-As and telomere length in blood in
both study groups (Figure 1). Increasing U-As was significantly
associated with both higher log2-mtDNAcn and with longer
telomere length in Chaco, and to a lesser extent for both
outcomes in Andes (models 1 and 2; Table 2). Among the
Andean women, we made further adjustments for estimated cell
proportions of white blood cells (CD4 and CD8 T-cells, B-cells,
natural killer cells, monocytes, and granulocytes). MtDNAcn
and telomere length were not significantly correlated with the
estimated cell proportion for any cell type. When adjusting the
analyses for estimated cell proportions, the effect estimates for U-
As decreased between 9 and 10% for log2-mtDNAcn and about
2% for telomere length, but the associations still remained with
p < 0.05. We also adjusted the analyses for chewing of coca-
leaves in the Andes: the effect estimates for U-As did not change
for mtDNAcn, but increased 3% for telomere length. Finally, we
excluded people with hyperkeratosis in Chaco, and we found
that the association between U-As and mtDNAcn or U-As and
telomere length were not driven by these individuals, and the
associations still remained below p = 0.05.
Modification by Arsenic Metabolism
Efficiency
Because the arsenic metabolism efficiency has been shown to be
a susceptibility factor for arsenic-related disease (Antonelli et al.,
2014), we further evaluated the role of the arsenic metabolism for
effects of arsenic on telomere length and mtDNAcn. We found
statistically significant interactions between %iAs and U-As, as
well as between %DMA and U-As on the effect of log2-mtDNAcn
in the Andes (adjusted models, p = 0.013 for %iAs, p = 0.0083
for %DMA), but not in Chaco (Table 3). After stratifying the data
sets at the median values of %iAs and %DMA, there were, both
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rS = 0.11 
p= 0.078
rS = 0.13 
p= 0.054
rS = 0.33 
p < 0.001
rS = 0.43 
p < 0.001
A B
C D
FIGURE 1 | Arsenic in urine is associated with higher copy number of mitochondrial DNA (log2-transformed, abbreviation mtDNAcn) and longer
telomeres in blood. Scatter plots depicting relations between urinary arsenic (sum of inorganic arsenic metabolites) concentrations and log2-mtDNAcn and telomere
length in Andes (A,B) and Chaco (C,D).
TABLE 2 | Associations of U-Asa with log2-mtDNAcn and telomere length in peripheral blood.
Marker/study group Model 1b Model 2c
n β (95% CI) p-value β (95% CI) p-value
mtDNAcn
Andes 244 0.028 (−0.014 to 0.069) 0.19 0.025 (−0.017 to 0.066) 0.24
Chaco 159 0.031 (0.011 to 0.050) 0.0024 0.027 (0.0069 to 0.046) 0.0085
TELOMERE LENGTH
Andes 208 0.0071 (0.00012 to 0.014) 0.046 0.0075 (0.00078 to 0.014) 0.029
Chaco 159 0.019 (0.0070 to 0.032) 0.0024 0.016 (0.0045 to 0.028) 0.0066
aU-As referred to as sum of urinary arsenic metabolites.
bLog2-mtDNAcn/telomere length = α + β1 × U-As (per 100µg/L).
cLog2-mtDNAcn/telomere length = α + β1 × U-As (per 100µg/L) + β2 × age + β3 × gender.
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TABLE 3 | Multivariable regression analyses of the associations between U-As and log2-mtDNAcn stratified for arsenic metabolism efficiency (above and
below median of fraction of each metabolite)a.
Study group mtDNAcnb % iAs n β1 (95% CI)
c p-valuec p-valued
Andes 0.56 <11 122 −0.018 (−0.076 to 0.039) 0.53 0.013
0.58 ≥11 122 0.084 (0.022 to 0.15) 0.0080
Chaco 0.76 <17 80 0.012 (−0.020 to 0.044) 0.45 0.82
0.93 >17 79 0.028 (0.0019 to 0.054) 0.036
% DMA
Andes 0.58 <80.9 122 0.076 (0.017 to 0.13) 0.011 0.0083
0.56 ≥80.9 122 −0.030 (−0.092 to 0.031) 0.33
Chaco 0.94 <71.1 79 0.027 (0.0038 to 0.049) 0.023 0.83
0.77 ≥71.1 80 0.020 (−0.038 to 0.079) 0.49
aU-As referred to as sum of urinary arsenic metabolites.
bPresented as median relative values of mtDNAcn.
cLog2-mtDNAcn = α + β1 × U-As (per 100µg/L) + β2 × age + β3 × gender.
dp-value for interaction (β4) from the equation: Log2-mtDNAcn = α + β1 × U-As (per 100µg/L) + β2 × age + β3 × gender + β4 × (U-As × < and > median %iAs/%MMA/%DMA).
TABLE 4 | Multivariable regression analyses of the associations between U-As and telomere length stratified for arsenic metabolism efficiency (above
and below median of fraction of each metabolite)a.
Study group TLb % iAs n β1 (95% CI)
c p-valuec p-valued
Andes 0.41 <11 94 0.0024 (−0.0089 to 0.014) 0.67 0.35
0.45 ≥11 114 0.0089 (0.00036 to 0.017) 0.041
Chaco 1.01 <17 80 0.011 (−0.0059 to 0.028) 0.20 0.35
1.19 >17 79 0.018 (0.0019 to 0.034) 0.029
% DMA
Andes 0.45 <80.9 114 0.0069 (−0.0012 to 0.015) 0.093 0.73
0.41 ≥80.9 94 0.0051 (−0.0076 to 0.018) 0.43
Chaco 1.23 <71.1 79 0.012 (−0.0028 to 0.026) 0.11 0.61
1.001 ≥71.1 80 0.024 (−0.0053 to 0.054) 0.11
aU-As referred to as sum of urinary arsenic metabolites. The number of individuals in Andes in each < and ≥ median split groups varied for telomere length as telomere length
measurements were only available for individuals sampled in 2008.
bPresented as median relative values of telomere length.
cTelomere length = α + β1 × U-As (per 100µg/L) + β2 × age + β3 × gender.
dp-value for interaction (β4) from the equation: telomere length = α + β1 × U-As (per 100µg/L) + β2 × age + β3 × gender + β4 × (U-As × < and > median %iAs/%MMA/%DMA).
in Andes and Chaco, significant positive associations between U-
As and log2-mtDNAcn among individuals with high %iAs and
low %DMA, but not among individuals with low %iAs and high
%DMA.
There were no significant interactions between fractions of
arsenic metabolites and U-As on telomere length (Table 4).
However, in the stratified analyses, statistically significant
positive associations between U-As and telomere length were
only found among individuals with high %iAs in both
the study groups. There was less of a clear pattern for
modification by %DMA or by %MMA (Supplementary Material
Table S4).
DISCUSSION
In this study, we explored associations of arsenic exposure
through drinking water, assessed by the concentration of arsenic
metabolites in urine, with carcinogenic markers (telomere length
and mtDNAcn) in two study groups with different ethnic
backgrounds. We found that the effect of arsenic exposure varied
between the study groups. In Chaco, arsenic exposure showed
persuasive associations with both telomere length andmtDNAcn,
but this was not so clear in the Andes, where only association
was found with telomere length. This discordance in effects likely
relates to variation in the efficiency of arsenic metabolism: the
Chaco individuals had, compared with the Andes, in general
less-efficient metabolism, reflected by higher fractions of iAs
and MMA and lower fractions of DMA in urine. Associations
between U-As and the DNA markers were observed also in the
Andean study group, but only in the individuals with less efficient
metabolism, i.e., with highest fraction of iAs in urine. These
findings stress the role of arsenic metabolism in the toxicity of
arsenic, and that some individuals and population groups, due to
their lower capacity for arsenic biotransformation, might bemore
susceptible to arsenic toxicity than others. We recently reported
a signal for genetic selection in the AS3MT gene in people in the
Andes (Schlebusch et al., 2013, 2015), partly overlapping with the
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present study group, and our data here support our hypothesis
that the indigenous people in the Andes show fewer adverse
effects of arsenic exposure due to a long-term adaptation to an
arsenic-rich environment, compared with a study group like the
Chaco, where people have lived in an arsenic-contaminated area
for much shorter time.
Similar to our study, others have found that blood mtDNAcn
increased in response to exposure to different carcinogenic
hazards, such as exposure to low levels of benzene, maternal
smoking, and sun exposure (Carugno et al., 2012; Gebhard
et al., 2014; Stangenberg et al., 2015), but there are only few
studies addressing the influence of arsenic on mtDNAcn. One
study reported increased mitochondrial biogenesis and function
in arsenic-induced skin cancer patients compared with healthy
subjects (Lee et al., 2011). In contrast, human-hamster AL
cells treated with high concentrations of sodium arsenite (0.5–
1mg/L), showed decreased mtDNAcn along with increased large
heteroplasmic mtDNA deletions (Partridge et al., 2007). It has
been suggested that the increased oxidative stress from exposure
to toxic compounds has a dual influence on the mtDNA (Hou
et al., 2010). Mild stress might stimulate mtDNA synthesis and
increase the number of mitochondria to fulfill the need for
cellular respiratory capacity for cell survival. However, excessive
oxidative stress may cause decreased mtDNA synthesis, possibly
due to increasing defects in mitochondria resulting in apoptosis
and cell death (Hou et al., 2010). This duality in response to
mild vs. excessive oxidative stress might also explain previous
findings on the effects of arsenic on telomere length. In human
cord blood cells, sub-nM arsenite increased TERT (the main
telomere-maintaining enzyme) gene and protein expression
in vitro, resulting in maintained telomere length, while at
1µM arsenite, TERT expression and telomere length decreased
(Ferrario et al., 2009). In people exposed to arsenic via drinking
water (1–1000µg/L) in Inner Mongolia, TERT expression was
positively associated with arsenic concentrations in water and in
fingernails, and with the severity of arsenic related hyperkeratosis
(Mo et al., 2009). The latter should be noted as we found a family
in Chaco demonstrating hyperkeratosis. This family did not have
longer telomeres, but did have more mtDNAcn compared with
the individuals without hyperkeratosis in Chaco. These findings,
however, should be very cautiously interpreted as they were based
on few study subjects.
We found a significant correlation between telomere length
and mtDNAcn in both study groups. TERT maintains telomere
length under oxidative stress, but in a time- and dose-
dependent manner, TERT gets excluded from the nucleus and
localizes in the mitochondria, giving protection by decreasing
mitochondrial superoxide production and cell peroxide levels
(Ahmed et al., 2008). One can hypothesize that in our study with
low to moderate exposure to arsenic, arsenic stimulates TERT
expression, which in turn results in telomere lengthening as well
as stimulation of mitochondrial DNA production.
However, in prospective studies, longer telomeres in blood
have been associated with increased risk for lung (Shen et al.,
2011; Seow et al., 2014) and pancreatic cancers (Lynch et al.,
2013). We found in both study groups that arsenic was associated
with longer telomeres in blood, even after taking cell profiles
in blood into account. This confirms earlier findings (Ferrario
et al., 2009) and provides strong evidence that arsenic has a
true positive effect on telomeres. Arsenic causes lung cancer
(International Agency for Reseasrch on Cancer, 2012), and our
findings here suggests a mechanistic link that this occurs by
lengthening of the telomeres. Higher mtDNAcn in blood has
in one prospective study been associated with increased risk of
breast cancer (Thyagarajan et al., 2013; Lemnrau et al., 2015),
and in case-control studies been linked to head and neck cancer
(Cheau-Feng Lin et al., 2014), prostate cancer (Zhou et al., 2014),
and chronic lymphocytic lymphoma (Hosnijeh et al., 2014). Of
these cancer forms, arsenic has to some extent been associated
with breast and prostate cancer (López-Carrillo et al., 2014;
Bardach et al., 2015). MtDNAcn seems to be a promising marker
for future cancer risk, but these women need to be followed up
in order to evaluate the actual link between arsenic, mtDNAcn,
telomere length and cancer.
Telomere length and mtDNAcn levels differed between the
study groups, where the Andean study group showed much
lower median values of mtDNAcn and telomere length compared
with the Chaco study group. We speculate that this disparity
is related to their ethnic backgrounds and living conditions,
particularly the differences in altitude. High altitude is correlated
with high hemoglobin (Ameer et al., 2015), and in turn high iron
levels in blood. Iron concentrations is associated with increased
oxidative stress (Tuomainen et al., 2007), which could shorten the
telomeres and affect the mtDNA contents.
In conclusion, we here provide evidence that arsenic exposure
through drinking water increases the telomere length and
mtDNAcn, two pre-carcinogenic markers, and that the arsenic
methylating capacity modifies the degree of DNA changes.
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